1,257
Views
4
CrossRef citations to date
0
Altmetric
Review Articles

Prospective and challenges of live bacterial therapeutics from a superhero Escherichia coli Nissle 1917

& ORCID Icon
Pages 611-627 | Received 04 Mar 2022, Accepted 01 Aug 2022, Published online: 10 Aug 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shuang Li & Yi-Xuan Zhang. (2023) Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics. Critical Reviews in Microbiology 0:0, pages 1-14.
Read now

Articles from other publishers (3)

Chuan-Chieh Hsiang, Shih-I Tan, Yeong-Chang Chen & I-Son Ng. (2023) Genetic design of co-expressing a novel aconitase with cis-aconitate decarboxylase and chaperone GroELS for high-level itaconic acid production. Process Biochemistry 129, pages 133-139.
Crossref
Yu-Chi Tseng, Chengfeng Xue & I-Son Ng. (2023) Symbiosis culture of probiotic Escherichia coli Nissle 1917 and Lactobacillus rhamnosus GG using lactate utilization protein YkgG. Process Biochemistry 126, pages 163-170.
Crossref
Haojie Chen, Pengyu Lei, Hao Ji, Qinsi Yang, Bo Peng, Jiahui Ma, Yimeng Fang, Linkai Qu, Hua Li, Wei Wu, Libo Jin & Da Sun. (2023) Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies. Materials Today Bio 18, pages 100543.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.